580 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
companies, excess tax benefit from share-based compensation, income tax effect of adjusted reconciling items and others that are listed in the itemized … in public companies, share-based compensation expense and the effects of any discrete income tax items. Management has excluded the effects
8-K
EX-99.1
91kwlz rx8
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
8-K/A
EX-99.1
oly75g9n
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K/A
gubrxo5wiu
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K
EX-99.1
3x26lvbeu cq1diuv7n
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-10.1
pmcbc0tm7jivozhobpq
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-99.1
5fy n1wu5ongv6it
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
4b7zsda
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
fay8d8m618u5texze
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm